Robot-assisted radical prostatectomy in low- and high-risk prostate cancer patients.

about

Robot-assisted radical prostatectomy in low- and high-risk prostate cancer patients.

Item

http://www.wikidata.org/entity/Q42086017

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Robot-assisted radical prostatectomy in low- and high-risk prostate cancer patients.

@en

Robot-assisted radical prostatectomy in low- and high-risk prostate cancer patients.

@nl

type

Item

label

Robot-assisted radical prostatectomy in low- and high-risk prostate cancer patients.

@en

Robot-assisted radical prostatectomy in low- and high-risk prostate cancer patients.

@nl

prefLabel

Robot-assisted radical prostatectomy in low- and high-risk prostate cancer patients.

@en

Robot-assisted radical prostatectomy in low- and high-risk prostate cancer patients.

@nl

P1476

Robot-assisted radical prostatectomy in low- and high-risk prostate cancer patients.

@en

P2093

Ahmet Bindayi

http://www.w3.org/2001/XMLSchema#string

Eyüp Gümüş

http://www.w3.org/2001/XMLSchema#string

Eyüp Veli Küçük

http://www.w3.org/2001/XMLSchema#string

Fikret Fatih Önol

http://www.w3.org/2001/XMLSchema#string

Uğur Boylu

http://www.w3.org/2001/XMLSchema#string

P2860

Predicting 15-year prostate cancer specific mortality after radical prostatectomy.

Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up.

Systematic review and meta-analysis of studies reporting urinary continence recovery after robot-assisted radical prostatectomy.

Comparative risk-adjusted mortality outcomes after primary surgery, radiotherapy, or androgen-deprivation therapy for localized prostate cancer.

Contemporary trends in low risk prostate cancer: risk assessment and treatment

A quantitative analysis of the prevalence of clinical depression and anxiety in patients with prostate cancer undergoing active surveillance.

Prospective quality-of-life outcomes for low-risk prostate cancer: Active surveillance versus radical prostatectomy.

Prostate cancer-specific mortality after radical prostatectomy for patients treated in the prostate-specific antigen era.

Lead time and overdiagnosis in prostate-specific antigen screening: importance of methods and context

Systematic review and meta-analysis of studies reporting potency rates after robot-assisted radical prostatectomy.

P304

36-41

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5152/TUD.2016.09476

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-01-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28270949

http://www.w3.org/2001/XMLSchema#string

P932

5330266

http://www.w3.org/2001/XMLSchema#string